OsseoScrew Versus Fenestrated Pedicle Screws Augmented With Polymethylmethacrylate (EVOLVE)
This study is currently recruiting participants.
Verified October 2012 by Alphatec Spine, Inc.
Sponsor:
Alphatec Spine, Inc.
Information provided by (Responsible Party):
Alphatec Spine, Inc.
ClinicalTrials.gov Identifier:
NCT01613144
First received: May 31, 2012
Last updated: October 30, 2012
Last verified: October 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
This is an Open-label, prospective, randomized, multi-center post-market study.
| Condition |
|---|
|
Osteoporosis Poor Bone Quality |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
| Official Title: | Expandable Pedicle Screws Versus Fenestrated Pedicle Screws Augmented With Polymethylmethacrylate (PMMA): Complications and Clinical Outcomes in Patients With Osteoporosis or Poor Bone Quality |
Resource links provided by NLM:
Further study details as provided by Alphatec Spine, Inc.:
Secondary Outcome Measures:
- Fusion [ Time Frame: 24 month ] [ Designated as safety issue: No ]
Successful fusion at 24 month post treatment as determined by:
- Presence of bridging bone
- Angular motion < 3 deg
- Translation motion < 2mm
- Oswestry Disability Index [ Time Frame: 24 month ] [ Designated as safety issue: No ]
- VAS back and leg pain [ Time Frame: 24 month ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 150 |
| Study Start Date: | May 2012 |
| Estimated Study Completion Date: | September 2015 |
| Estimated Primary Completion Date: | March 2015 (Final data collection date for primary outcome measure) |
| Groups/Cohorts |
|---|
| OsseoScrew |
| Fenestrated Screw |
Detailed Description:
To collect clinical evidence of safety and efficacy of the OsseoScrew Spinal Fixation System versus fenestrated pedicle screws augmented with polymethylmethacrylate (PMMA) in patients with Osteoporosis or Poor Bone Quality
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Probability Sample |
Study Population
150 skeletally mature study subjects with spinal instability and osteopenia will be enrolled in the study. Subjects will be randomized 1:1 to the OsseoScrew or the control group.
Criteria
Inclusion Criteria:
- ≥ 18 years of age
- Spinal instability or deformity requiring fusion with instrumentation
- Osteopenia defined as (T-Score of less than -1.0)
- No response to nonoperative treatment modalities preceding enrollment.
- Subject is willing and able to provide informed consent and agrees to release medical information for purposes of this study and to return for scheduled follow-up evaluations
Exclusion Criteria:
- Active systemic or local infection
- A life expectancy less than the study duration
- Autoimmune disorders
- Currently an alcohol, solvent, or drug abuser
- Psychiatric or cognitive impairment that, in the opinion of the investigator, would interfere with the subject's ability to comply with the study requirements
- History of allergies to any of the device components including but not limited to commercially pure titanium, titanium alloy, polymethylmethacrylate or Zirconium Oxide (ZrO2)
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01613144
Contacts
| Contact: Bita P Ghadimi | Bghadimi@alphatecspine.com |
Locations
| Belgium | |
| O.L. Vrouwziekenhuis | Recruiting |
| Aalst, Belgium | |
| ULB Hopital Erasme | Recruiting |
| Bruxelles, Belgium | |
| CHIREC parc Leopold | Recruiting |
| Bruxelles, Belgium | |
| CHC St. Joseph | Recruiting |
| Liege, Belgium | |
| Germany | |
| Katholische Klinikum Marienhof | Recruiting |
| Koblenz, Germany | |
| UNIVERSITÄTSMEDIZIN der Johannes-Gutenberg Universität Mainz | Recruiting |
| Mainz, Germany | |
| Spain | |
| Hospital de Leon | Recruiting |
| Leon, Spain | |
Sponsors and Collaborators
Alphatec Spine, Inc.
More Information
No publications provided
| Responsible Party: | Alphatec Spine, Inc. |
| ClinicalTrials.gov Identifier: | NCT01613144 History of Changes |
| Other Study ID Numbers: | REC-000784 |
| Study First Received: | May 31, 2012 |
| Last Updated: | October 30, 2012 |
| Health Authority: | Germany: Ethics Commission |
Additional relevant MeSH terms:
|
Osteoporosis Bone Diseases, Metabolic Bone Diseases Musculoskeletal Diseases Polymethyl Methacrylate Vasodilator Agents |
Cardiovascular Agents Therapeutic Uses Pharmacologic Actions Antimutagenic Agents Protective Agents Physiological Effects of Drugs |
ClinicalTrials.gov processed this record on May 23, 2013